Corporate / Financial / News and Highlights

News and Highlights



 

2012-04-25 Vitrolife is nominated for SwedenBIO Award 2012th.

Winner will be chosen on SwedenBIO's Annual Meeting on May 24. The other nominees are Atlas Antibodies and Moberg Derma. See additional info in the press release (in Swedish).

 

   

 

2012-01-18 "Fruitful years wait Vitrolife"

is the header of the share analysis by the Aktiespararna.se. They see good possibilities with new products and increased sales at emerging markets. Read the whole article (in Swedish)

 

2011-12-15 Equity portfolios in 2012 - article in the magazine "Veckans Affärer"

The stock market analysts at Veckans Affärer have chosen equity portfolios for the year 2012 with high, medium and low risk. 4 shares in each portfolio are expected to beat the index. Vitrolife is chosen as one of the companies in the medium risk portfolio. For more information, see Veckans Affärer 2011-12-15, part 1, page 46 - 48 "Ut med riskerna - in med helt nya aktier" (In Swedish)